WELLAND MEDICAL LIMITED
Get an alert when WELLAND MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-14 (in 8mo)
Last made up 2025-12-31
Watchouts
None on the register
Cash
£897K
+51.9% vs 2023
Net assets
£16M
+16.8% vs 2023
Employees
277
+9.9% vs 2023
Profit before tax
£5M
+60.3% vs 2023
Name history
Renamed 1 time since incorporation
- WELLAND MEDICAL LIMITED 1987-12-01 → present
- HEVLEX LIMITED 1987-09-29 → 1987-12-01
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £40,592,105 | £45,657,166 | |
| Operating profit | £3,419,198 | £5,478,909 | |
| Profit before tax | £3,418,690 | £5,478,909 | |
| Net profit | £2,725,770 | £3,796,245 | |
| Cash | £590,712 | £897,104 | |
| Total assets less current liabilities | £14,831,697 | £17,483,837 | |
| Net assets | £13,686,350 | £15,982,595 | |
| Equity | £13,686,350 | £15,982,595 | |
| Average employees | 252 | 277 | |
| Wages | £8,898,411 | £10,151,877 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 8.4% | 12.0% | |
| Net margin | 6.7% | 8.3% | |
| Return on capital employed | 23.1% | 31.3% | |
| Current ratio | 1.99x | 2.02x | |
| Interest cover | 6730.70x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EDE, Joanne | Secretary | 2024-12-01 | — | — |
| DUCKWORTH, Sarah Anne | Director | 2022-01-01 | Jan 1975 | British |
| FARBROTHER, Sean Lea | Director | 2012-01-01 | Sep 1967 | British |
| SADA, Claude Husain | Director | 2026-05-06 | Sep 1971 | French |
| SHORT, Stuart Michael | Director | 2024-03-01 | Dec 1970 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLISON, Ronald James | Secretary | 1997-09-23 | 1998-09-01 |
| BRYDEN, Suzanne | Secretary | 1998-09-01 | 2024-11-30 |
| HARKNESS, John Charles | Secretary | 1992-10-01 | 1997-01-30 |
| RAPER, Christopher John | Secretary | — | 1992-10-01 |
| BIDDULPH, Paul Ian | Director | 2012-04-01 | 2018-03-31 |
| FARBROTHER, Sean Lea | Director | 2008-02-18 | 2010-09-01 |
| HARKNESS, John Charles | Director | 1992-10-01 | 1997-01-30 |
| JAMES, Samantha Claire | Director | 2015-09-01 | 2026-03-31 |
| LEWIS, Lawrence Morris | Director | 1991-01-01 | 1997-01-31 |
| MARGETTS, David James | Director | 2002-03-01 | 2021-12-31 |
| MORRIS, Ernest Joseph | Director | 1993-11-11 | 1993-11-12 |
| PIERCEY, Dennis Alan | Director | 1997-10-01 | 1998-09-01 |
| PIERCEY, Nigel Denis | Director | 1997-01-31 | 2012-01-01 |
| PRIMETT, Christopher Donald | Director | 2006-03-06 | 2020-03-31 |
| RAPER, Christopher John | Director | — | 2012-01-01 |
| RIGLAR, Jonathan Edgar | Director | 2022-03-01 | 2024-02-29 |
| SHELLEY, Nicholas Steven | Director | 1996-01-01 | 2006-02-28 |
| SHEPHERD, Harry Arthur | Director | — | 1992-05-31 |
| SMITH, Rory James Maxwell, Dr | Director | 1996-01-01 | 1999-04-26 |
| WYNN, Mathew Daren | Director | 2017-04-01 | 2022-08-09 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Clinimed (Holdings) Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 183 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-06 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-21 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-08 | AA | accounts | Accounts with accounts type full | |
| 2025-01-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-02 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-12-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-10-10 | AA | accounts | Accounts with accounts type full | |
| 2024-03-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-29 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-13 | CH01 | officers | Change person director company with change date | |
| 2023-10-06 | AA | accounts | Accounts with accounts type full | |
| 2023-01-30 | CH01 | officers | Change person director company with change date | |
| 2023-01-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-05 | AA | accounts | Accounts with accounts type full | |
| 2022-08-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-03-08 | AP01 | officers | Appoint person director company with name date | |
| 2022-01-04 | AP01 | officers | Appoint person director company with name date | |
| 2022-01-04 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+12.5%
£40,592,105 £45,657,166
-
Cash
+51.9%
£590,712 £897,104
-
Net assets
+16.8%
£13,686,350 £15,982,595
-
Employees
+9.9%
252 277
-
Operating profit
+60.2%
£3,419,198 £5,478,909
-
Profit before tax
+60.3%
£3,418,690 £5,478,909
-
Wages
+14.1%
£8,898,411 £10,151,877
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers